Blog - Page 2 of 5773 - QualityStocks

WednesdayNov 04, 2026 9:45 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Broad Strategy Anchored by Science, Disciplined Growth

The scale of the need for neurological solutions is enormous; the World Health Organization reports that more than three billion people live with a neurological condition. Quantum focuses on neurodegenerative, metabolic and alcohol misuse disorders, pursuing a strategy that pairs pharmaceutical research with commercialization partnerships and licensing structures designed to support multiple potential revenue streams. The most advanced piece of the neurodegenerative strategy is Lucid-MS, a patented new chemical entity designed to address demyelination. Brain disorders touch more lives than almost any other area of medicine, yet they remain among the hardest to treat. Quantum BioPharma (NASDAQ: QNTM) is taking on…

WednesdayNov 04, 2026 9:00 am

MindWave Innovations Inc. (NYSE American: APUS) Builds Institutional Digital Asset Infrastructure Beyond Blockchain Security

MindWave is developing an integrated infrastructure model combining digital asset treasury, validator operations, insurance innovation, and real-world asset tokenization. Its MindChain Layer 2 and validator infrastructure are designed to complement technical security with institutional risk management and protection. New agreements to build and operate AssureChain and AQUAEChain demonstrate how MindChain can serve as infrastructure for specialized institutional networks. For institutions entering the digital asset economy, blockchain security is only one part of the risk equation. Audits, validator monitoring, secure custody and infrastructure controls can lower the risk of technical and operational failures, but they do not necessarily address what happens…

TuesdayNov 03, 2026 1:25 pm

QualityStocksNewsBreaks – IBNAi Token Begins Trading on SpotEx Centralized Exchange Against USDT

InvestorBrandNetwork AI (IBNAi), the native utility token of the IBN ecosystem, is now trading against Tether ("USDT") on the SpotEx.Trade centralized cryptocurrency exchange. The official listing of the IBNAI/USDT trading pair provides retail and institutional traders access to SpotEx's trading infrastructure, including limit, market and stop orders, real-time technical analysis tools, order book functionality and standard maker and taker fees of 0.2% per trade. SpotEx CEO and founder Soosho said the exchange aims to provide liquidity for IBNAi within the financial digital media and communications sector. The listing follows the October launch of the IBNAi Wallet, which reportedly has more…

TuesdayNov 03, 2026 10:30 am

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Advances Overwatch Integration with European Drone Manufacturer

Disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI has signed an MOU with a European drone manufacturer to integrate and evaluate its Overwatch positioning platform on two fixed-wing unmanned aerial vehicle (“UAV”) platforms. The agreement also incorporates Overwatch Intelligence, designed to consolidate positioning, observation and movement data from connected aircraft into a unified operational view. Following operator-run field trials in Ukraine and the Middle East, SPARC AI is pursuing additional defense and commercial opportunities, including through a new regional advisory agreement. Reliable positioning is becoming an important consideration as autonomous systems expand into environments…

TuesdayNov 03, 2026 9:45 am

American Fusion(TM) Inc. (AMFN) Reports Four Texatron(TM) Commercial Proposals as Pulsed-Power Testing Advances

Four commercial proposals for potential Texatron(TM) fusion program deployments remain under active discussion. The company is pursuing discussions with data center developers as it explores a model in which it would own and operate future Texatron(TM) systems and sell electricity under long-term agreements. American Fusion(TM) has upgraded electrical switching equipment and configured higher-capacity capacitor banks for the next phase of Texatron(TM) pulsed-power experiments. A technical manuscript prepared by Chief Technology Officer Dr. John E. Brandenburg is undergoing scientific review, with publication and public release planned after the formal process is completed. American Fusion(TM) (OTCBQ: AMFN), developer of next-generation fusion energy…

TuesdayNov 03, 2026 9:10 am

QualityStocksNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Innovations Featured in CryptoCurrencyWire Podcast

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) through its wholly owned subsidiary MindWave Innovations Inc., is featured in the latest CryptoCurrencyWire Audio Production released by IBN. During the interview with IBN's Carmel Fisher, MindWave CEO Dr. Vin Menon discusses the development of MindChain, an institutional blockchain platform designed to combine digital asset infrastructure with insurance protection. Menon outlines the subsidiary's efforts to establish enterprise blockchain ecosystems across multiple industries, including climate technology, media and advertising, and insurance. These initiatives include a ClimateTech partnership with AQUAE Impact, an AdTech agreement involving a Nasdaq-listed company and an InsurTech ecosystem under development to…

TuesdayNov 03, 2026 9:00 am

QualityStocksNewsBreaks – IBN Introduces North America Media Network to Expand Regional News Distribution Across U.S. and Canada

IBN, a multifaceted communications organization with an extensive portfolio of digital media brands, announced the launch of the IBN North America Media Network, a new addition to its content syndication and press distribution platform. The network encompasses hundreds of geographically focused news outlets across the United States and Canada, providing businesses and organizations with additional opportunities to distribute corporate announcements, financial news and other content to regional audiences. Participating publications serve major metropolitan areas, states, provinces and smaller regional markets, including New York, Los Angeles, Chicago, Houston, Toronto, Vancouver and Calgary. The new network complements IBN's existing Core Syndication Network…

TuesdayNov 03, 2026 9:00 am

Earth Science Tech Inc. (ETST) Wins Through the Inherent Operating Leverage of Its ‘Conglomerate’ Business Model

Earth Science Tech’s ‘conglomerate’ business model has allowed it to leverage its internal tech stack, real estate, as well as ingredient-sourcing and manufacturing capabilities to capture the profit margins at every step that other companies are forced to outsource The company is focused on building a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment Earth Science Tech now augments its healthcare operations through investments in real estate, asset management activities, and consumer products business Earth Science Tech (OTCQB: ETST) is a strategic holding company that brings together innovative businesses across the healthcare,…

MondayNov 02, 2026 11:15 am

Adaptogenics Health Corp. (CSE: ADPT) Targets Supply, Verification, Traceability in Emerging Peptide Market

Disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. The movement toward a regulated peptide market is increasing its momentum. A responsible peptide market needs four things: dependable supply, documented traceability, independent verification and better products grounded in evidence. Better products are the longer-term goal, and Adaptogenics’ research programs will be built around defined biological endpoints and development milestones. Peptides are moving from the fringes of wellness culture toward the regulated pharmacy counter. Whether that shift protects patients will depend on something less visible than policy: proof of what is actually in each vial. Adaptogenics Health (CSE:…

MondayNov 02, 2026 10:30 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) Draws ‘Men’s Fitness’ Spotlight as Unbuzzd Trial Shows Early Promise

Earlier this month, “Men’s Fitness,” reviewed the unbuzzd clinical trial and described the early study findings as “promising.” Results showed that estimated blood alcohol concentration was significantly lower and participants experienced improved self-rated alertness and lower headache severity. For operators in this space, the stakes reach beyond the morning after. Most recovery drinks promise relief after a night out, yet few have been tested against a placebo in a registered human trial. One that has is now getting a close look from a major fitness publication. Quantum BioPharma (NASDAQ: QNTM), a biopharmaceutical company developing therapies for neurodegenerative, metabolic and alcohol misuse disorders,…

Site Search

Company Search